Ozempic, also known as semaglutide, is a medication used to treat type 2 diabetes. It works by mimicking the natural hormone glucagon-like peptide-1 (GLP-1), which is involved in glucose regulation [1].
Before meals, Ozempic helps regulate blood sugar levels by slowing down gastric emptying and reducing appetite. Gastric emptying refers to the emptying of food from the stomach into the small intestine for digestion. By slowing down this process, Ozempic reduces the peak blood glucose levels that occur after a meal [2].
Additionally, Ozempic stimulates the release of insulin, the hormone that helps to lower blood glucose levels, and suppresses the release of glucagon, a hormone that raises blood glucose levels. This results in a decreased postprandial glucose excursion [3].
According to DrugPatentWatch.com, Ozempic is approved for use in the United States for the treatment of type 2 diabetes, and its effectiveness in regulating blood sugar levels has been demonstrated in several clinical trials [4].
Sources:
[1] DrugPatentWatch.com. (n.d.). Semaglutide. Retrieved from https://www.drugpatentwatch.com/semaglutide/
[2] European Medicines Agency. (n.d.). Ozempic. Retrieved from https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic
[3] Novo Nordisk. (n.d.). Ozempic. Retrieved from https://www.novonordisk.com/ozempic/
[4] DrugPatentWatch.com. (n.d.). Ozempic. Retrieved from https://www.drugpatentwatch.com/ozempic/